Dark Light

Harvard Diabetes Comorbidities and Complications 2023


$70.00

Date • July 31 – August 3, 2023

UPDATE IN DIABETES COMORBIDITIES AND COMPLICATIONS

State-of-the-Art Approaches to Assessment, Risk Reduction, and Management
 
This comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:

Obesity
Cardiovascular Disease
Heart Failure
Coronary Artery Disease
Hypertension
Hyperglycemia
Hypoglycemia
Dyslipidemia
Non-Alcoholic Fatty Liver Disease
Peripheral Vascular Disease
Chronic Kidney Disease
Sexual Dysfunction

Sessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:

Advancing your knowledge of diabetes comorbidities and complications
Delivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions
Optimizing clinical decision-making
Improving patient outcomes

In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.
EDUCATIONAL HIGHLIGHTS
This program provides strategies, updates, and new practice recommendations to improve your care of patients with diabetes. Coverage includes:

Evaluating cardiovascular and renal risk in patients with diabetes
Adjusting pharmacological therapies in the patient with diabetes complications
Evaluating, managing, and monitoring diabetic CKD
Obesity management: when to consider new therapeutic and surgical options
Diagnosis and management of coronary artery disease in the patient with diabetes
Management and prevention of kidney disease
Hypertension and cholesterol management: customizing targets and treatment strategies for each patient
Practical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA
Heart failure: improving patient functional capacity with combined therapies
New methods for managing peripheral vascular disease in diabetes patients
Updates in the prevention and management of hypoglycemia
Current guidelines for treating non-alcoholic fatty liver disease
Evaluation and management of sexual dysfunction in patients with diabetes
The expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease
Lifestyle medicine interventions: how to get patients to initiate and sustain healthy behavioral changes
Innovation in stem cell therapies for diabetes patients
Diabetes in pregnancy: new diagnosis and treatment guidelines
Advances in glucose monitors, insulin pumps, and diabetes apps
What the latest data tell us about diabetes prevention and risk assessment
Important developments in insulin therapy
Combining innovative therapeutic combinations with traditional approaches
Strategies to assess and manage interacting comorbidities
Medication interactions: avoiding adverse outcomes

Social, Racial, Sexual, and Cultural Differences in Diabetes Care Needs
We are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:

Management of diabetes and related disorders in diverse racial/ethnic populations
Recognizing biases: strategies for achieving equity and addressing disparities
Establishing and maintaining connections with patients

Schedule
Print

All times listed below are Eastern Daylight Time.

Monday, July 31, 2023

8:00am to 8:15am

Welcome and Introduction

A. Enrique Caballero, MD and Romela Petrosyan, MD

OBESITY MANAGEMENT

8:15am to 8:45am

Medical Treatment of Obesity: Updates and Best Practices for Individualizing Therapies

Bartolome Burguera, MD

8:45am to 9:15am

Advances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes

Philip Schauer, MD

9:15am to 10:00am

Q & A and Clinical Case Discussion

Bartolome Burguera, MD and Philip Schauer, MD

10:00am to 10:15am

Break

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below

Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

10:15am to 11:05am

CARDIOVASCULAR – Diagnosis and Management of Heart Failure in the Patient with Diabetes: What Every Physician Now Needs to Know

Akshay Desai, MD

10:15am to 11:05am

METABOLIC – Updates in Continuous Glucose Monitoring and Insulin Pumps in Diabetes Management

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

11:05am to 11:10am

Break

ADVANCES in HYPERTENSION MANAGEMENT

11:10am to 11:55am

Hypertension Management in the Patient with Diabetes: A Practical Approach

Naomi Fisher, MD

11:55am to 12:00pm

Wrap-Up of Day 1

Course Directors

Tuesday, August 1, 2023

8:00am to 8:05am

Welcome and Introduction to Day 2 Activities

A. Enrique Caballero, MD and Romela Petrosyan, MD

UPDATES in DIABETES MANAGEMENT

8:05am to 8:40am

Adjusting Pharmacological Therapies in the Patient with Diabetes Complications

Marie McDonnell, MD

8:40am to 9:15am

Updates in the Prevention and Management of Hypoglycemia

Devin Steenkamp, MD

9:15am to 10:00am

Q & A and Clinical Case Discussion
Marie McDonnell, MD and Devin Steenkamp, MD

10:00am to 10:15am

Break

Concurrent Breakout Sessions

 

10:15am to 11:05am

CARDIOVASCULAR – Diagnosis and Management of Coronary Artery Disease in the Patient with Diabetes: Practical Tools for the Busy Clinician

Christopher Cannon, MD

10:15am to 11:05am

METABOLIC – Weight Variability and Diabetes Complications

Antonio Ceriello, MD

11:05am to 11:10am

Break

ADVANCES in the MANAGEMENT of DYSLIPIDEMIA

11:10am to 11:55am

Updates, Innovations, and Advances for the Management of Dyslipidemia in the Patient with Diabetes
Om Ganda, MD

11:55am to 12:00pm

Wrap-Up of Day 2

Course Directors

Wednesday, August 2, 2023

8:00am to 8:05am

Welcome and Introduction to Day 3 Activities

A. Enrique Caballero, MD and Romela Petrosyan, MD

UPDATES for CARDIOVASCULAR and RENAL RISK REDUCTION

in the PATIENT with DIABETES

8:05am to 8:30am

Practical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction

Vanita Aroda, MD

8:30am to 8:55am

KEYNOTE: The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular, and Renal Disease: Implications for Clinical Practice

Deepak Bhatt, MD

8:55am to 9:20am

KEYNOTE: The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes: Recent Data and Practical Implications

George Bakris, MD

9:20am to 10:00am

Q & A and Clinical Case Discussion

Vanita Aroda, MD, Deepak Bhatt, MD, and George Bakris, MD

10:00am to 10:15am

Break

Concurrent Breakout Sessions

 

10:15am to 11:05am

CARDIOVASCULAR – Updates in the Evaluation and Management of Peripheral Vascular Disease in the Patient with Diabetes

Allen D. Hamdan, MD

10:15am to 11:05am

METABOLIC – Diabetes in Pregnancy: New Diagnosis and Treatment Guidelines

Florence Brown, MD

11:05am to 11:10am

Break

THE EDWARD S. HORTON LECTURE

11:10am to 11:55am

Management of Diabetes and Related Disorders in Diverse Racial/Ethnic Populations

A. Enrique Caballero, MD

11:55am to 12:00pm

Wrap-Up of Day 3

Course Directors

Thursday, August 3, 2023

8:00am to 8:05am

Welcome and Introduction to Day 4 Activities

A. Enrique Caballero, MD and Romela Petrosyan, MD

CHRONIC KIDNEY DISEASE

in the PATIENT with DIABETES

8:05am to 8:40am

Evaluation and Monitoring of Diabetic CKD
Romela Petrosyan, MD

8:40am to 9:15am

KEYNOTE: Current Clinical Guidelines for the Management of CKD in Diabetes

Katherine R. Tuttle, MD, FASN, FACP, FNKF

9:15am to 10:00am

Q & A and Clinical Case Discussion

Romela Petrosyan, MD and Katherine R. Tuttle, MD, FASN, FACP, FNKF

10:00am to 10:15am

Break

Concurrent Breakout Sessions

Choose either of the two breakout sessions listed below

10:15am to 11:05am

CARDIOVASCULAR – Evaluation and Management of Sexual Dysfunction in Patients with Diabetes

Martin N. Kathrins, MD

10:15am to 11:05am

METABOLIC – Updates and Best Practices for State-of-the-Art Insulin Therapy

Guillermo Umpierrez, MD

11:05am to 11:10am

Break

ADVANCES in NON-ALCOHOLIC FATTY LIVER DISEASE

11:10am to 11:55am

Diagnosis and Management of Non-Alcoholic Fatty Liver Disease

Ken Cusi, MD

11:55am to 12:00pm

Closing Remarks

Course Directors